EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via Serping1 in Cardiac Fibroblasts

Parisa Aghagolzadeh iD, Lifen Xu iD, Philipp Klinger iD, Christian Morandi, Lilia Maryse Lépine iD, Lukas Minder iD, Pieter-Jan Guns iD, Matthias Bosman, Marie-May Coissieux, Thierry Pedrazzini, Gabriela Kania iD, Marijke Brink iD

International Journal of Molecular Sciences · 21.05.2026 · 27 (10) · 4616

DOI: 10.3390/ijms27104616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.05.2026. Verfasst von Parisa Aghagolzadeh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cardiobiology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland. Hauptthemen laut MEDLINE: Doxorubicin, Neuregulin-1, Cardiotoxicity, Fibroblasts. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, the Horizon 2020 ERA.Net RUS Plus, Horizon 2020 ERA.Net RUS Plus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anthracyclines such as doxorubicin (DOX) are widely used in cancer treatment, but their benefits are offset by dose-related cardiotoxicity. Neuregulin-1β (NRG1) has been studied as a cardioprotective factor, yet its mechanisms during DOX treatment, particularly in the presence of cancer, are not well understood. This study evaluated daily recombinant NRG1 co-administered with DOX in 4T1-tumor-bearing female BALB/c mice. The mice were randomized to saline, DOX (3 mg/kg i.p. on days 0, 3, 6, 9; cumulatively 12 mg/kg) or DOX + NRG1 (20 µg/kg i.p. daily, starting one day before DOX). Body weight and tumor growth were monitored throughout treatment. Cardiac structure and function were assessed by transthoracic echocardiography at baseline and before sacrifice. Mechanistic studies included left ventricular proteomics and single-cell RNA-seq. We also used human 3D cardiac microtissues and 2D primary cardiac fibroblast-enriched cultures under defined experimental conditions, with targeted fibroblast gene perturbations. We found that early DOX exposure induced systolic dysfunction and pathological remodeling, while daily NRG1 preserved the ejection fraction and attenuated structural changes without impairing anti-tumor efficacy. Proteomic analysis identified Serping1 as one of the most strongly upregulated proteins soon after DOX exposure, an effect that was reversed by NRG1. Notably, Serping1 has not previously been implicated in anthracycline cardiotoxicity or NRG1-mediated protection. Single-cell RNA sequencing localized Serping1 expression to cardiac fibroblasts. Mechanistically, we found that Serping1 modulation was associated with altered Igfbp5 processing and fibroblast survival under DOX-induced stress; its suppression by NRG1 was linked to reduced fibroblast apoptosis and a shift toward a pro-survival-associated state. In human cardiac microtissues, NRG1 treatment or fibroblast-specific Serping1 knockdown accelerated cardiomyocyte contraction dynamics. These changes occurred without an increase in apoptosis and point to a paracrine effect of fibroblasts on cardiomyocyte function. Additionally, scRNA-seq revealed an Erbb4+ fibroblast subpopulation associated with early pro-fibrotic activation that expanded after DOX but was reduced by NRG1. Taken together, NRG1 preserved cardiac function during anthracycline treatment while maintaining anti-tumor efficacy. Our data identify fibroblast-associated signaling, particularly through Serping1, as a potential contributor to the early protective effects of NRG1. These findings add a new dimension to the understanding of NRG1 cardioprotection and suggest that fibroblast–myocyte interactions may contribute to the early cardiac response to DOX.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinNeuregulin-1CardiotoxicityFibroblastsAnimalsFemaleHumansMiceMice, Inbred BALB CMyocardiumAntibiotics, Antineoplastic

Stichwörter der Autor:innen

anthracycline cardiotoxicitycardiac fibroblastscardiac remodelingcardioprotection

Substanzen

DoxorubicinNeuregulin-1Antibiotics, Antineoplastic

Autor:innen und Institutionen

  • Cardiobiology, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.
  • Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
  • Laboratory of Physiopharmacology, Faculty of Medicine and Health Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Campus Drie Eiken, University of Antwerp, 2610 Antwerp, Belgium.
  • Laboratory of Tumor Heterogeneity, Metastasis and Resistance, Department of Biomedicine, University of Basel and University Hospital Basel, 4031 Basel, Switzerland.
  • School of Cardiovascular and Metabolic Medicine and Sciences, MRC/BHF Centre of Research Excellence in Advanced Cardiac Therapies, King's College London, London WC2R 2LS, UK.

ORCID-Profile: Parisa Aghagolzadeh, Lifen Xu, Philipp Klinger, Lilia Maryse Lépine, Lukas Minder, Pieter-Jan Guns, Gabriela Kania, Marijke Brink

Förderung

  • Swiss National Science Foundation
  • the Horizon 2020 ERA.Net RUS Plus
  • Horizon 2020 ERA.Net RUS Plus
  • Stiftung für Kardiovaskuläre Forschung Basel

Zitieren

APA

Aghagolzadeh, P., Xu, L., Klinger, P., Morandi, C., Lépine, L. M., Minder, L., Guns, P. J., Bosman, M., Coissieux, M. M., Pedrazzini, T., Kania, G., & Brink, M. (2026). Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via Serping1 in Cardiac Fibroblasts. International Journal of Molecular Sciences, 27(10), 4616. https://doi.org/10.3390/ijms27104616

Vancouver

Aghagolzadeh P, Xu L, Klinger P, Morandi C, Lépine LM, Minder L, et al. Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via Serping1 in Cardiac Fibroblasts. International Journal of Molecular Sciences. 2026;27(10):4616. doi:10.3390/ijms27104616

BibTeX
@article{Aghagolzadeh2026,
  author = {Aghagolzadeh, Parisa and Xu, Lifen and Klinger, Philipp and Morandi, Christian and Lépine, Lilia Maryse and Minder, Lukas and Guns, Pieter-Jan and Bosman, Matthias and Coissieux, Marie-May and Pedrazzini, Thierry and Kania, Gabriela and Brink, Marijke},
  title = {Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via Serping1 in Cardiac Fibroblasts},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4616},
  doi = {10.3390/ijms27104616}
}
Kostenlos starten →